113
Participants
Start Date
December 3, 2021
Primary Completion Date
July 15, 2024
Study Completion Date
March 27, 2025
VRDN-001 Phase 3 Cohort (THRIVE)
5 IV Infusions of veligrotug (VRDN-001) 10mg/kg
VRDN-001 Placebo
5 IV Infusions of veligrotug (VRDN-001) placebo
Sydney Eye Hospital, Sydney
North Shore Eye Surgery, Sydney
New York Eye Ear Infirmary of Mount Sinai, New York
Hospital Arruzafa, Córdoba
Complexo Hospiralario Universitario de Santiago-Hospital Medico-Ciruxico de Conxo, Santiago
West Virgina University Eye Insitute, Morgantown
Clinica Universidad de Navarra, Madrid
Hospital Universitario Ramon y Cajal, Madrid
Clinica Universidad de Navarra, Pamplona
Sina Medical Center, Homestead
Med-Care Research Inc., Miami
Edward Jenner Research Group Center LLC, Plantation
Sarasota Retina Institue, Sarasota
Universitatsmedizin Gottingen, Göttingen
Hospital Universitatio Virgen De La Macarena, Servicio de Oftalmologia, Seville
Fraser Eye Care Center, Fraser
Kahana Oculoplastic & Orbital Surgery, Livonia
CHU d'Angers, Angers
Hospital Universitario Miguel Servet, Servicio de Paseo Isabel La Catdlica1, Zaragoza
Johannes Gutenberg-University Medical Center, Mainz
University of Minnesota, Department of Ophthalmology and Visual Neurosciences, Minneapolis
Vision Medical Research Inc., Orland Park
University Health Diabetes, Endocrinology & Nephrology Center, Kansas City
KU Medical Center, University of Kansas, Kansas City
Centre Hospitalier National D'ophtalmologie, Paris
AP-HP- Hopital de la Pitie Salpetriere, Paris
Baylor College of Medicine (BCM)-Opthalmology, Houston
Neuro-Eye Clinical Trials, Houston
Neuro-Ophthalmology of Texas PLLC, Houston
University of Colorado - Department of Ophthalmology, Aurora
University of Colorado, Aurora
Advanced Research International, LLC, Las Vegas
USC Roski Eye Institute, Los Angeles
MACRO Trials, Inc., Los Angeles
The Private Office of Raymond Douglas, Beverly Hills
Amy Patel Jain, MD, Newport Beach
University of California, San Francisco, San Francisco
Byers Eye Institute/Stanford University, Palo Alto
Senta Clinic, San Diego
Massachusetts Eye and Ear, Boston
Ophthalmic Consultants of Boston, Weymouth
Rutgers-New Jersey Medical School-Newark, Newark
University of Vermont Medical Center, Burlington
CH Nice, Nice
NZOZ E-Vita, Bialystok
Specjakistyczny Osrodek Okulistyczny Oculomedica, Bydgoszcz
Santa Familia PTG Lodz, Lodz
Panstwowy Instytut Medycsny MSWiA, Warsaw
4 Wojskowy Szpital Kliniczny z Polikinika SP ZOZ, Wroclaw
Clinica Bonanova de Cirugia Ocular, Barcelona
Northwick Park Hospital, London
Western Eye Hospital Imperial College NHS trust, London
Guy's and St. Thomas NHS Trust, London
Viridian Therapeutics, Inc.
INDUSTRY